Literature DB >> 1159416

On the synchronizing effect of amantadine-1-hydrochlorid (Symmetrel) on pathological EEG-activity.

J Vardi, M Streifler.   

Abstract

The pathological EEG of a 60 years old lady who suffered from an organic mental syndrome with parkinsonian features, showed diffuse, slow asynchroneous activity. Administration of Symmetrel repeatedly and consistently caused a normalization of the EEG, while its discontinuation immediately led to the reappearance of the original desynchronized pattern. These EEG changes were not accompanied by any modifications in the patients' clinical condition. This discrepancy between the antiparkinsonian and the synchronizing effect of Symmetrel upon the EEG can be explained by a specific activity on the reticulo-thalamo-cortical pathways in addition to that upon the nigro-striatal tracts.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1159416     DOI: 10.1007/bf01249767

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  12 in total

1.  Diffuse projection systems: the integrative action of the thalamic reticular system.

Authors:  H Jasper
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1949-11

2.  Possible association between triphasic E.E.G. waves and disorder of dopaminergic systems.

Authors:  A M Hamoen
Journal:  Br Med J       Date:  1973-08-04

3.  The effect of sleep on spike-wave discharges in absence seizures.

Authors:  S Sato; F E Dreifuss; J K Penry
Journal:  Neurology       Date:  1973-12       Impact factor: 9.910

4.  Mechanisms of the states of sleep: a neuropharmacological approach.

Authors:  M Jouvet
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1967

5.  Amantadine actions on acetylcholine and GABA in striatum and substantia nigra of rat in relation to behavioral changes.

Authors:  I J Bak; R Hassler; J S Kim; K Kataoka
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

6.  Amantadine in the treatment of Parkinson's disease.

Authors:  R S Schwab; A C England; D C Poskanzer; R R Young
Journal:  JAMA       Date:  1969-05-19       Impact factor: 56.272

7.  Levodopa in hepatic coma.

Authors:  J D Parkes; P Sharpstone; R Williams
Journal:  Lancet       Date:  1970-12-26       Impact factor: 79.321

8.  Jakob-Creutzfeldt disease: treatment by amantadine.

Authors:  J Braham
Journal:  Br Med J       Date:  1971-10-23

9.  Norepinephrine-containing neurons: changes in spontaneous discharge patterns during sleeping and waking.

Authors:  N Chu; F E Bloom
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728

10.  Dopamine: release from the brain in vivo by amantadine.

Authors:  P F Von Voigtlander; K E Moore
Journal:  Science       Date:  1971-10-22       Impact factor: 47.728

View more
  2 in total

Review 1.  Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.

Authors:  B K Young; R Camicioli; L Ganzini
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

2.  Kleine-Levin syndrome with periodic apnea during hypersomnic stages--E.E.G. study.

Authors:  J Vardi; S Flechter; M Tupilsky; J M Rabey; R Carasso; M Streifler
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.